Post-prandial amylin concentrations are increased by sulphonylurea, but unchanged by basal insulin, in NIDDM

Samankaltaisia teoksia

• Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
  Tekijä: Rachman, J, et al.
  Julkaistu: (1998)
• Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
  Tekijä: Rachman, J, et al.
  Julkaistu: (1997)
• A practical guide to basal and prandial insulin therapy.
  Tekijä: Holman, R, et al.
  Julkaistu: (1985)
• Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement.
  Tekijä: Holman, R, et al.
  Julkaistu: (1987)
• RESTING THE BETA-CELLS WITH INSULIN IN NIDDM DOES NOT IMPROVE BETA-CELL FUNCTION NOR PROINSULIN PROCESSING
  Tekijä: Rachman, J, et al.
  Julkaistu: (1995)